ANDA 214458, held by Taro. Aminocaproic Acid.
As of Nov 15, 2026, ANDA 214458 (Aminocaproic Acid), held by Taro, was first approved by FDA on Mar 24, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 24, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Aminocaproic Acid0.25GM/ML ยท solution;oral | Aminocaproic Acid | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
